Clinical efficacy of probiotics in improving intestinal mucosal permeability for functional dyspepsia patients with anxiety
Frontiers in Microbiology · 18.06.2025 · 16
DOI: 10.3389/fmicb.2025.1614705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 18.06.2025. Verfasst von Kang-Ming Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Sanming First Hospital Affiliated to Fujian Medical University, Sanming, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The aim of this study was to investigate whether probiotics are effective in improving symptoms of functional dyspepsia (FD) accompanied by anxiety.
Methods
There were 116 patients with FD accompanied by anxiety and 114 patients without anxiety. Each group was randomly divided into an intervention group and a control group. The intervention group received probiotics in addition to conventional acid suppression and gastric protection, as well as prokinetic treatments. The control group received conventional treatment plus a placebo.
Results
Before treatment, significant differences were observed in IL-1, IL-6, TNF- α , LPS, Zonulin, DAO, and I-FABP between patients with FD accompanied by anxiety and those without anxiety ( p < 0.05). Following the intervention with probiotics, the group with FD and anxiety experienced significant decreases in IL-1, IL-6, TNF- α , LPS, Zonulin, and DAO ( p < 0.001), as well as significant reductions in the Patient Assessment of Gastrointestinal Disorders-Symptom Severity Index (PAGI-SYM) and the Hamilton Anxiety Scale (HAMA) scores ( p < 0.001). In contrast, the intervention group with FD but without anxiety had significant reductions in IL-6 and TNF- α ( p < 0.05), along with a significant decrease in the PAGI-SYM score ( p < 0.001). Binary logistic regression analysis further revealed that lower I-FABP values (OR = 0.999, p = 0.036), lower LPS values (OR = 0.998, p = 0.013), and probiotic intervention (OR = 5.138, p = 0.000) were significantly associated with symptom relief.
Conclusion
The intervention significantly improved the symptoms and anxiety scores of patients with FD and anxiety, and the changes in intestinal mucosal permeability indexes were closely related to symptom relief and anxiety improvement, Probiotic interventions may be an effective means of improving symptoms in patients with FD. Clinical trial registration identifier ChiCTR2300077847 https://www.chictr.org.cn/ .
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Sanming First Hospital Affiliated to Fujian Medical University, Sanming, China.
- Department of Endoscopy Room, Sanming First Hospital Affiliated to Fujian Medical University, Sanming, China.
- Department of Nephrology, Sanming First Hospital Affiliated to Fujian Medical University, Sanming, China.
Zitieren
APA
Huang, K. M., Qiu, H. B., Liao, D. P., Jiang, Y. Y., Deng, Y. H., & Chen, H. B. (2025). Clinical efficacy of probiotics in improving intestinal mucosal permeability for functional dyspepsia patients with anxiety. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1614705
Vancouver
Huang KM, Qiu HB, Liao DP, Jiang YY, Deng YH, Chen HB. Clinical efficacy of probiotics in improving intestinal mucosal permeability for functional dyspepsia patients with anxiety. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1614705
BibTeX
@article{Huang2025,
author = {Huang, Kang-Ming and Qiu, Hua-Bin and Liao, Dong-Ping and Jiang, Ya-Yue and Deng, Ying-Han and Chen, Hong-Bin},
title = {Clinical efficacy of probiotics in improving intestinal mucosal permeability for functional dyspepsia patients with anxiety},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1614705}
}
EUVIMED